loading
전일 마감가:
$79.99
열려 있는:
$79.59
하루 거래량:
2.82M
Relative Volume:
0.64
시가총액:
$247.80B
수익:
$56.53B
순이익/손실:
$8.32B
주가수익비율:
29.82
EPS:
2.6798
순현금흐름:
$8.49B
1주 성능:
-1.32%
1개월 성능:
+8.00%
6개월 성능:
+5.62%
1년 성능:
-8.48%
1일 변동 폭
Value
$79.37
$80.09
1주일 범위
Value
$79.35
$81.52
52주 변동 폭
Value
$61.24
$87.67

아스트라제네카 ADR Stock (AZN) Company Profile

Name
명칭
Astrazeneca PLC
Name
전화
44 20 3749 5000
Name
주소
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge
Name
직원
61,100
Name
트위터
@AstraZeneca
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
AZN's Discussions on Twitter

AZN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Major icon
AZN
Astrazeneca PLC
79.90 248.01B 56.53B 8.32B 8.49B 2.6798

아스트라제네카 ADR Stock (AZN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-15 개시 Exane BNP Paribas Outperform
2025-02-13 업그레이드 UBS Neutral → Buy
2025-02-12 개시 Morgan Stanley Overweight
2024-11-20 업그레이드 UBS Sell → Neutral
2024-11-06 업그레이드 Deutsche Bank Sell → Hold
2024-09-13 다운그레이드 Deutsche Bank Hold → Sell
2024-05-30 개시 Goldman Buy
2024-04-16 업그레이드 Deutsche Bank Sell → Hold
2024-02-08 다운그레이드 Deutsche Bank Hold → Sell
2024-01-23 개시 Morgan Stanley Overweight
2024-01-16 재개 UBS Sell
2024-01-03 다운그레이드 Jefferies Buy → Hold
2023-12-18 개시 HSBC Securities Buy
2023-09-25 업그레이드 Jefferies Hold → Buy
2023-07-14 개시 HSBC Securities Buy
2023-07-12 업그레이드 UBS Neutral → Buy
2023-07-05 다운그레이드 Deutsche Bank Buy → Hold
2023-04-11 업그레이드 Morgan Stanley Equal-Weight → Overweight
2023-01-05 개시 BMO Capital Markets Outperform
2022-09-15 다운그레이드 Credit Suisse Outperform → Neutral
2022-09-07 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2022-08-29 업그레이드 Argus Hold → Buy
2022-06-14 다운그레이드 UBS Buy → Neutral
2022-02-11 업그레이드 DZ Bank Sell → Hold
2021-12-07 다운그레이드 Jefferies Buy → Hold
2021-08-12 재개 JP Morgan Overweight
2021-04-12 다운그레이드 Argus Buy → Hold
2021-03-16 업그레이드 Jefferies Hold → Buy
2021-02-25 업그레이드 UBS Neutral → Buy
2021-01-15 개시 Deutsche Bank Buy
2020-12-07 업그레이드 Morgan Stanley Equal-Weight → Overweight
2020-11-30 업그레이드 UBS Sell → Neutral
2020-11-11 업그레이드 HSBC Securities Reduce → Hold
2020-09-29 개시 Berenberg Buy
2019-11-22 개시 SVB Leerink Outperform
2019-10-25 업그레이드 Liberum Hold → Buy
2019-04-02 다운그레이드 UBS Neutral → Sell
2019-02-05 개시 Exane BNP Paribas Outperform
2019-01-25 업그레이드 Shore Capital Hold → Buy
2018-12-11 재개 Jefferies Hold
2018-10-09 개시 Guggenheim Buy
2018-08-16 다운그레이드 Jefferies Buy → Hold
2018-03-19 업그레이드 Jefferies Hold → Buy
2018-02-06 재확인 Leerink Partners Mkt Perform
2018-02-05 재확인 Bernstein Outperform
2018-01-18 재확인 Leerink Partners Mkt Perform
2017-12-29 업그레이드 JP Morgan Neutral → Overweight
2017-10-16 업그레이드 Credit Suisse Neutral → Outperform
2017-09-25 업그레이드 Exane BNP Paribas Neutral → Outperform
2017-09-22 업그레이드 Bernstein Mkt Perform → Outperform
모두보기

아스트라제네카 ADR 주식(AZN)의 최신 뉴스

pulisher
03:52 AM

AstraZeneca's Hypertension Drug Lowers Blood Pressure in 'Meaningful, Sustained' Manner - MarketScreener

03:52 AM
pulisher
Aug 30, 2025

Technical analysis overview for AstraZeneca PLC Depositary Receipt stock2025 Volume Leaders & Technical Confirmation Trade Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

How to recover losses in AstraZeneca PLC Depositary Receipt stockPortfolio Gains Summary & Free Safe Entry Trade Signal Reports - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Shareholders that lost money on AstraZeneca PLC (AZN) should contact Levi & Korsinsky about pending Class ActionAZN - ACCESS Newswire

Aug 30, 2025
pulisher
Aug 30, 2025

What institutional flow reveals about AstraZeneca PLC Depositary ReceiptPortfolio Return Report & Low Volatility Stock Suggestions - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Signal strength of AstraZeneca PLC Depositary Receipt stock in tech scannersJuly 2025 Trade Ideas & Verified Entry Point Detection - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Real time scanner hits for AstraZeneca PLC Depositary Receipt explainedWatch List & Weekly Breakout Stock Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

What momentum shifts mean for AstraZeneca PLC Depositary ReceiptProfit Target & Consistent Return Investment Signals - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

AstraZeneca is said to seek approval for antihypertensive this year - Seeking Alpha

Aug 30, 2025
pulisher
Aug 30, 2025

AstraZeneca Faces Close Race With Mineralys After Phase III Hypertension Readout - insights.citeline.com

Aug 30, 2025
pulisher
Aug 30, 2025

15.7mmHg Blood Pressure Reduction: AstraZeneca's Novel Drug Shows Breakthrough in Treatment-Resistant HTN - Stock Titan

Aug 30, 2025
pulisher
Aug 30, 2025

AstraZeneca to seek approval for blood pressure drug by year-end - MarketScreener

Aug 30, 2025
pulisher
Aug 29, 2025

What candlestick patterns are forming on AstraZeneca PLC Depositary Receipt2025 Stock Rankings & AI Forecasted Stock Moves - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

SGLT2 Inhibitors Market to Hit USD 29.73 Billion by 2032, Driven by Expanding Diabetes Management and Cardiovascular Benefits – SNS Insider - GlobeNewswire Inc.

Aug 29, 2025
pulisher
Aug 29, 2025

AstraZeneca PLC (AZN) Oncology Sales Hit $12B in H1 2025 - MSN

Aug 29, 2025
pulisher
Aug 28, 2025

AstraZeneca Challenges Colo. Law Over Drug Pricing Rules - Law360

Aug 28, 2025
pulisher
Aug 28, 2025

Characterization of Astrazeneca’s AZD-0233 for cardiovascular disease - BioWorld MedTech

Aug 28, 2025
pulisher
Aug 28, 2025

Gout Pipeline 2025: Detailed Clinical Trials and FDA-Approved Therapies Review | AstraZeneca, R-Pharm, Allena Pharma, JW Pharma, Hinova pharma, Jiangsu Hengrui Medicine, Selecta Biosciences, LG Chem - Barchart.com

Aug 28, 2025
pulisher
Aug 28, 2025

Is a relief rally coming for AstraZeneca PLC Depositary Receipt holdersRate Cut & Real-Time Volume Analysis - Newser

Aug 28, 2025
pulisher
Aug 27, 2025

University of Michigan Suit Targets AstraZeneca FluMist Profits - Bloomberg Law News

Aug 27, 2025
pulisher
Aug 27, 2025

AstraZeneca’s DESTINY-Endometrial01 Study: A New Horizon in Endometrial Cancer Treatment - MSN

Aug 27, 2025
pulisher
Aug 27, 2025

AstraZeneca increasing focus on US market, as it is 'first to provide access to patients': CFO [Video] - AOL.com

Aug 27, 2025
pulisher
Aug 27, 2025

AstraZeneca and Icon Plc’s Study on ATTR Amyloidosis: Key Insights for Investors - TipRanks

Aug 27, 2025
pulisher
Aug 27, 2025

Published on: 2025-08-27 11:23:01 - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Published on: 2025-08-27 08:26:33 - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Va. backs big pharma deals for AstraZeneca in Albemarle, Eli Lilly in Goochland - Richmond Times-Dispatch

Aug 27, 2025
pulisher
Aug 27, 2025

Can swing trading help recover from AstraZeneca PLC Depositary Receipt losses2025 Volatility Report & Weekly Consistent Profit Watchlists - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Evaluating AstraZeneca PLC Depositary Receipt with trendline analysis2025 Big Picture & Accurate Entry and Exit Point Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Tools to monitor AstraZeneca PLC Depositary Receipt recovery probabilityWeekly Market Report & Weekly Top Gainers Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

AstraZeneca bounces back from scandal in China - Financial Times

Aug 27, 2025
pulisher
Aug 26, 2025

AstraZeneca PLC Depositary Receipt Recovery Hinges on Volume Breakout getLinesFromResByArray error: size == 0 - 더경남뉴스

Aug 26, 2025
pulisher
Aug 26, 2025

AstraZeneca Sees Increase in Voting Rights by The Capital Group - TipRanks

Aug 26, 2025

아스트라제네카 ADR (AZN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
자본화:     |  볼륨(24시간):